Lower riskDrug recall · FDA · Published April 24, 2023
Harvard Drug Group Recalls Gabapentin Tablets Due to Foreign Tablet Mixup
Harvard Drug Group recalls 600mg Gabapentin tablets (NDC 0904-6823-61) after finding a foreign tablet in some products. This recall is for prescription-only items sold between specific dates.
“Harvard Drug Group Recalls Gabapentin Tablets Due to Foreign Tablet Mixup.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33725-harvard-drug-group-recalls-gabapentin-tablets-due-to-foreign-tablet. Based on FDA recall #D-0570-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0570-2023%22&limit=1).
The Harvard Drug Group voluntarily recalled Gabapentin Tablets, USP 600 mg on April 24, 2023, after a foreign tablet was found in the product, according to the FDA. The recall affects cartons distributed nationwide.
How to tell if you have it
Brand: The Harvard Drug Group
Product: Gabapentin Tablets, USP 600 mg
Packaging: Cartons of 100 tablets (10 tablets per blister pack x 10)
NDC: 0904-6823-61
Lot: T04468
Expiration: 10/2024
Quantity: 3984 cartons
The hazard
The hazard is a product mixup involving one foreign tablet found in the Gabapentin Tablets, USP 600 mg, according to the FDA.
Context
GovInfoNow's records show The Harvard Drug Group has 20 other recalls on record since July 15, 2016. Other recent recalls of similar products include Golden State Baclofen Tablets Recall: Foreign Tablets Risk (Nov. 26, 2025), Graviti Furosemide Tablets Recall: Foreign Substance Hazard (Jan. 10, 2026), and Golden State Medical Supply Primidone Tablets Recall: Cross Contamination Risk (April 27, 2026).
How to tell if you have this one
Check for the NDC code 0904-6823-61 and lot number T04468 on the packaging. The product is a prescription-only 600mg Gabapentin tablet in cartons of 100 tablets.
Brand
The Harvard Drug Group
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Packaging
Look for the NDC code 0904-6823-61 and lot number T04468 on the packaging to confirm if your product is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0570-2023 (April 24, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0570-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.